Tilray Stock Loses Traction: Can the Quarterly Report Turn Things Around?
Announced Tuesday, April 23, the Tilray (NASDAQ:TLRY) quarterly report will be posted in May. At the time of writing, Tilray stock is trading at $50.70, which puts the cannabis stock down 2.16%. Tilray Stock in ... [Read]
Tilray Stock: Why has this Once-Favorite Stock Declined so Fast?
Despite its size, Tilray (NASDAQ:TLRY) has been a poor performer on the stock market this year. April has, thus far, been particularly rough. Tilray stock has dropped from approximately $63 USD to $52.91 (at present), ... [Read]
TLRY Stock: Insider Selling is New Headache for Tilray
TLRY stock might have kicked off the post IPO period in the most perfect way, but it is finding it hard to emulate the $6.69 billion valuation. During its IPO, one share of the Tilray ... [Read]
TLRY Stock: Tilray Receives New License From Health Canada
TLRY stock continues to decrease despite news that Tilray (NASDAQ:TLRY) has received a new processing license from Health Canada to expand its manufacturing capacity at its Natura greenhouse, which will allow the facility to produce ... [Read]
Tilray Q4 Results: What to Expect and How is TLRY Stock Reacting
Tilray will release its Q4 and fiscal full-year 2018 results at market close today, March 18th. Cannabis investors will be watching closely, largely because the company promised to increase recreational sales in the quarter. This ... [Read]
TLRY Stock: Tilray Completes First Successful Harvest in Portugal
TLRY stock drops as medical cannabis producer Tilray Inc (NASDAQ:TLRY) makes a strong push into the EU. Yesterday, the Nanaimo, British Columbia-based cannabis company announced the completion of its first medical cannabis harvest at its ... [Read]
CBD Kiosks Pop-Up as Cannabis Revolution Comes to a Mall Near You
NEW YORK, Mar. 1, 2019 /CNW/ -- Growing acceptance of cannabidiol (CBD) is resulting in heightened visibility, as CBD-infused products are now hitting malls across the USA. Marketed as aiding in the reduction of anxiety, inflammation and other ailments, ... [Read]
Tilray Stock: Mega Hemp Deal Could Mean Mega US-Hemp Growth
Tilray stock climbs as medical cannabis producer Tilray Inc. (NASDAQ:TLRY) enters the hemp industry with a massive acquisition of Manitoba Harvest. TLRY is up 0.72% and selling for $77.95 USD at the time of writing. ... [Read]
Tilray Stock: Tilray Doubles Canadian Cultivation, Watch out Canada!
Cannabis stocks have corrected today after most were shining green at market open. There have been some major announcements by major cannabis players today, but that didn't seem to affect cannabis shares at all. We'll ... [Read]
Tilray Stock Soars on News that Investment Firm Won’t Sell its 75M Shares
It was quite the day for Tilray stock. On Friday, January 11th, Privateer Holdings announced that it does not plan to sell its 75 million shares of Tilray Inc; this is a fear many investors ... [Read]